OTC: SATT

SATIVUS TECH CORP.

CIK 0001661600 · SIC 8742 · Management Consulting Services

Micro Revenue $36K Assets $268K as of Sep 6, 2026

SATIVUS TECH CORP. (formerly SEEDO CORP.) (the “Company”, “Our” or “We”) was formed on January 16, 2015, under the laws of the State of Delaware. Prior to July 2020, we were involved in producing a plant growing device managed and controlled by an artificial intelligent algorithm, allowing… About this business →

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.

10-Q Filed Aug 13, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jul 20, 2026 · Period ending Jul 1, 2026

Summary not yet generated.

Partner

Trade SATT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Apr 15, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K/A Filed Apr 15, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 17, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

8-K Filed Oct 21, 2025 · Period ending Oct 19, 2025

Summary not yet generated.

10-K Filed Mar 31, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

8-K Filed Oct 31, 2024 · Period ending Oct 28, 2024

Summary not yet generated.

S-1/A Filed Mar 15, 2016

Summary not yet generated.

S-1/A Filed Feb 8, 2016

Summary not yet generated.

S-1 Filed Dec 31, 2015

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 13, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)

dollars in thousands

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Operating expenses:
Research and development (95) (122) (172) (328)
General and administrative (63) (91) (134) (145)
Operating loss (158) (213) (306) (473)
Financial income (expenses), net 116 (209) 12 (47)
Net loss (42) (422) (294) (520)
Non-controlling interests (62) (90) (120) (187)
Net loss attributable to equity holders of the Company 20 (332) (174) (333)
Basic and diluted net loss per share (0.00) (0.08) (0.04) (0.08)
Weighted average number of Ordinary shares used in computing basic and diluted loss per share 4,215,571 4,215,571 4,215,571 4,215,571

Condensed Consolidated Balance Sheets

dollars in thousands

Description June 30, 2026 (Unaudited) December 31, 2025 (Audited)
ASSETS
CURRENT ASSETS:
Cash and cash equivalents 85 32
Restricted cash 10 9
Accounts receivable 21
Prepaid expenses and other receivables 9 41
Total current assets 104 103
NON-CURRENT ASSETS
Property and equipment, net 164 204
Total non-current assets 164 204
Total assets 268 307
LIABILITIES AND SHAREHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payables 297 267
Convertible loans 2,532 2,451
Loans from related party 125 98
Fair value of convertible component in convertible loans 618 726
Other accounts liabilities 321 296
Total current liabilities 3,893 3,838
SHAREHOLDERS’ DEFICIT
Ordinary shares of $0.0001 par value
Ordinary shares of $0.0001 par value Authorized: 500,000,000 shares at June 30, 2026 and December 31, 2025; Issued and Outstanding: 4,215,571 and 4,215,571 shares at June 30, 2026 and December 31, 2025, respectively 4 4
Additional Paid in capital 21,083 20,973
Accumulated deficit (24,652) (24,477)
(3,565) (3,500)
Non-controlling interests (60) (31)
Total shareholders’ deficit (3,625) (3,531)
Total liabilities and shareholders’ deficit 268 307

Condensed Consolidated Statements of Cash Flows (Unaudited)

dollars in thousands

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net income (loss) (294) (520)
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization 40 80
Share based compensation expenses to employees and non-employees 15
Financial expenses related to convertible loans and warrants 81 85
Change in fair value of convertible component in convertible loans (108) (75)
Changes in assets and liabilities:
Decrease (Increase) in other accounts receivable 32 6
Increase in accounts receivable 21 (4)
Decrease (Increase) in trade payables 30 216
Decrease (Increase) in other accounts payables 25 126
Net cash used in operating activities (173) (86)
Cash flows from investing activities:
Purchase of property and equipment, Net
Decrease (increase) in restricted cash (1) 5
Proceeds Loans from related party 27 74
Proceeds from Short term loans 78
Decrease (increase) in deposits
Net cash used in investing activities 26 157
Cash flows from financing activities:
Lease payments
Proceeds from convertible loans 36
Proceeds from issuance of shares to minority interests in subsidiary 200 38
Net cash provided (used) by financing activities 200 74
Increase (decrease) in cash and cash equivalents and restricted cash 53 145
Cash and cash equivalents and restricted cash at the beginning of the year 32 96
Cash and cash equivalents at the end of the period 85 241

Amounts as printed on the EDGAR/iXBRL face — dollars in thousands. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

About SATIVUS TECH CORP.

Source: Item 1 (Business) from the 10-K filed April 15, 2026. Description as filed by the company with the SEC.

Item 1. Description of Business.

SATIVUS TECH CORP. (formerly SEEDO CORP.) (the
“Company”, “Our” or “We”) was formed on January 16, 2015, under the laws of the State of Delaware.
Prior to July 2020, we were involved in producing a plant growing device managed and controlled by an artificial intelligent algorithm,
allowing consumers to grow their own herbs and vegetables effortlessly from seed to plant, while providing optimal conditions to assure
premium quality produce year-round. However, due to financial and operational difficulties and during 2020, we ceased these operations
and on July 19, 2020, the Company formed a new wholly-owned subsidiary in Israel, Hachevra Legiduley Pkaot Beisrael Ltd. (the “New
Subsidiary”), to develop a fully automated and remotely managed system for growing saffron and other vegetables. On November 5,
2020, the New Subsidiary changed its name to Saffron-Tech Ltd. (or “Saffron Tech”). As of the date of this report, and following
various financings in Saffron Tech, the Company owns 54% of Saffron Tech.

The Company, through Saffron Tech, is focusing
on development of agriculture and technological products, in the fields of exotic plants.

Saffron Tech has developed a comprehensive agronomic
and agrotechnical protocol for the cultivation of saffron. Moreover, the company has innovated proprietary Controlled Environment Agriculture
(CEA) technology, designed to execute, monitor, and optimize this cultivation protocol effectively. Furthermore, Saffron Tech has established
a meticulous extraction protocol to ensure the production of high-quality saffron extract. This holistic approach underscores the company's
commitment to advancing saffron cultivation and extraction through cutting-edge technological solutions.

Read full description ↓

Saffron Tech is poised to launch its proof of
concept pilot site for commercial saffron cultivation in the upcoming months. This initiative aims to introduce an advanced Controlled
Environment Agriculture (CEA) system, facilitating the year-round cultivation of saffron irrespective of external climatic conditions.
The system is engineered to ensure a continuous and dependable yield of saffron, maintaining consistent quality and quantity in a cost-effective
manner.

Saffron finds application across multiple sectors,
notably within the culinary realm where it is favored by renowned chefs and Michelin-starred establishments, the natural cosmetics sector,
and the nutraceuticals industry. The recognition of saffron for its medicinal properties, including its use as an antidepressant, antioxidant,
and antiseptic, is on the rise. The total Saffron Tech market opportunity evaluated as $2.3B in 2023, and is anticipated to grow up to
$3.7B by 2032. The market opportunity is based on the Saffron Marker, Saffron extraction market, and potential segments in the nutraceutical
and cosmetical use markets.

In April 2022, Saffron Tech announced its new
state-of-the-art indoor research and development center is operational. As of April 2022 Saffron Tech successfully completing four Saffron
cultivation cycles a year, using CEA, while traditional agriculture only produces one harvest of saffron per year.

On December 9, 2021, we implemented a 1-for-10
consolidation, or reverse split, of our issued and outstanding common shares. Except where otherwise indicated, all share and per share
data in this 10-K have been retroactively restated to reflect the reverse stock split.

On December 13, 2021,
the Company changed its name from Seedo Corp to Sativus Tech Corp. On the same day the Company also announced the appointment of Tal Wilk-Glazer
as the CEO of Saffron Tech. Wilk-Glazer joins Saffron-Tech after finishing her job at Salesforce as Salesforce’s Industries Eastern
Europe, Africa and Israel regional director.

1

On January 6, 2022, the Company announced that
its subsidiary, Saffron Tech, has planted approximately 25,000 Saffron bulbs in fields in the Golan Heights, in Northern Israel. The plantation
is being managed in conjunction with the Shamir Research Institute, which operates under the auspices of the Haifa University, Israel.

On April 4, 2022, the
Company announced that Mr. Moshe Bar Siman Tov and Mrs. Iris Tova Ginsburg have resigned from the Board of Directors of the Company,
and immediately appointment of Mrs. Tal Wilk-Glazer to its Board of Directors and as CEO of the Company.

On August 30, 2022, Saffron Tech, announced its
intention to raise up to 5 million New Israeli Shekels (“NIS”) (approximately $1.5 million) at a pre-money valuation of NIS
32.5 million (approximately $10 million) through the Israeli crowdfunding platform – Pipelbiz (“2022 Crowd Funding Round”).
Assuming the maximum amount is raised, the Company will own approximately 61% of the Saffron Tech. The 2022 Crowd Funding Round was closed
on December 1, 2022, having raised 3.8 million NIS (approximately $1.3 million). Fund raising expenses accumulated to $152 and the net
amount raised through Pipelbiz was $1.15 million. Saffron Tech also raised 1.15 million NIS (approximately $328 thousand) through the
issuance of SAFEs. The SAFEs are convertible at a 20% discount to the current crowd funding round. Sativus Tech’s interest in Saffron
Tech now totals 67.5% post-raise. All SAFEs were converted before December 31, 2024. Saffron Tech continued to raise funds through Pipelbiz
under the same pre-money valuation during December 2022 through to January 2023, via another crowd funding round “2023 Crowd Funding
Round” which closed on February 5, 2023, having raised another 1.1 million NIS (approximately $314 thousand).

On March 1, 2023, Saffron Tech entered into an
investment agreement with Korean-based company, Dreamtech Co Ltd (“Dreamtech”), a leading provider and manufacturer
of tech components for innovative products including advanced mobile and medical devices. Under this new agreement, Dreamtech will fund
an initial investment of $1 million followed by an additional $1 million upon a successful cultivation of saffron in Korea. Saffron Tech
aims to be the first company to create a large-scale production of saffron using vertical farming technology to meet the growing demand
of the spice for use in beauty, wellness, and pharmaceutical applications. Dreamtech and Saffron Tech started a mutual POC in Korea. The
POC results expected to be amounted in Q1/24. The Company’s interest in Saffron Tech now totals 54% post-raise.

On October 20th,
2025, our Director & CEO Mr. Shmulik Yannay resigned from the Board & his position as CEO. This was not the result of any disagreements
with the Company. On the same day, the Board appointed Mr. Michael Oster to replace Mr. Yannay as a Director and CEO. At the same time
the Board additionally appointed Mr. Shaul Trabelsi as a Director and Board Member.